Pilot Therapeutics Holdings Inc. (PLTT)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0000 - 0.0001 - Volume
200 - Avg. Volume
475 - Market Cap (intraday)
1,150 - Beta (5Y Monthly) -78.10
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pilot Therapeutics Holdings Inc. develops and manufactures pharmaceutical products for treatment of dysfunctional lipid metabolism. The company offers Airozin for asthma, PLT 1288 for arthritis, PLT 732 for cardiovascular disease and diabetes, and PLT 2753 for allergic rhinitis. Additionally, it provides clinical trials, personnel recruitment, sales and marketing, and raising capital services. Pilot Therapeutics Holdings Inc. was founded in 1998 and is based in the United States.
14
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: PLTT
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PLTT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PLTT
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-129.52%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-6.27M
Diluted EPS (ttm)
-0.5500
Balance Sheet and Cash Flow
Total Cash (mrq)
97.11k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.95M
Company Insights: PLTT
PLTT does not have Company Insights